Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

AUTHOR

OTS

DATE

July 5, 2020

CATEGORIES

Immune Stimulation

Post Views: 347

Buss CG, Bhatia SN.

Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13428-13436.

Pubmed

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.
August 5th, 2020|0 Comments
Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
July 5th, 2020|0 Comments
Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial
May 15th, 2020|0 Comments
Vaccination against non-mutated neoantigens induced in recurrent and future tumors

Vaccination against non-mutated neoantigens induced in recurrent and future tumors
April 30th, 2020|0 Comments
Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses
February 29th, 2020|0 Comments
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.

Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.
January 31st, 2020|0 Comments

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Related articles

Subscribe to our Newsletter

Resources

Stay Connected

Search

Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics.

Related articles

Hybridization Liquid Chromatography-Tandem Mass Spectrometry: An Alternative Bioanalytical Method for Antisense Oligonucleotide Quantitation in Plasma and Tissue Samples.

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists

Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial

Vaccination against non-mutated neoantigens induced in recurrent and future tumors

Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses

Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.

Subscribe to our Newsletter

Resources

Stay Connected

Search

Login to your account

Reset Password

Signup to your Account

Answers

Job Alerts

Account Activation